Trump Administration Unveils Plan to Lower Prescription Drug Costs

Washington D.C. - The Trump administration today detailed its plan to tackle rising prescription drug costs, a key promise made during the President's campaign. The plan focuses on several key areas: increasing transparency in drug pricing, promoting competition among drug manufacturers, and empowering Medicare to negotiate lower drug prices. Officials claim these measures will save consumers billions of dollars annually.

Meanwhile, a separate investigation reveals the impact of recent Medicaid cuts on rural healthcare. Many rural hospitals and clinics are struggling to stay open due to reduced funding, leading to limited access to essential medical services for residents. Patients are forced to travel longer distances for care, often delaying or forgoing treatment altogether. This situation underscores the challenges faced by rural communities in accessing affordable and quality healthcare.